

Who bears the financial loss when a Turkish company acquisition fails because regulatory approval is refused or delayed? Learn about competition clearance, regulatory conditions, termination rights, deposits, damages, and foreign investor remedies under Turkish law.
Acquiring a company in Turkey can be a significant investment opportunity for foreign businesses seeking access to manufacturing facilities, commercial networks, strategic assets, and established operations. However, some acquisitions cannot be completed without approval from regulatory authorities.
A transaction may require merger control clearance, sector-specific authorization, or other regulatory consent before the parties can lawfully complete the transfer of shares, assets, or control.
A serious dispute may arise when a foreign investor signs a share purchase agreement, pays a deposit, incurs substantial due diligence expenses, and arranges acquisition financing, only to discover that the necessary regulatory approval cannot be obtained.
The seller may refuse to return the deposit, claiming that the buyer assumed the regulatory risk. The buyer may argue that the seller failed to disclose licensing problems, provided inaccurate information, or breached its obligation to cooperate with the approval process.
In other situations, the parties may disagree about whether the buyer was required to accept restrictive regulatory conditions, dispose of certain assets, restructure the transaction, or extend the closing deadline.
For example, a foreign company may agree to acquire a Turkish business for USD 15 million, subject to regulatory clearance. After several months of negotiations and significant professional expenses, the competent authority refuses approval. The seller claims compensation for the failed transaction, while the foreign buyer demands repayment of its deposit and reimbursement of acquisition costs.
Who bears the loss depends primarily on the regulatory framework, the acquisition agreement, the reason approval was not obtained, and whether either party breached an enforceable obligation.
Under Turkish law, the failure to obtain regulatory approval does not automatically mean that the buyer must compensate the seller or that the seller must reimburse every expense incurred by the buyer.
The transaction documents may allocate regulatory risk through conditions precedent, cooperation obligations, long-stop dates, termination provisions, deposits, break fees, and indemnification clauses.
Turkish Code of Obligations No. 6098, Turkish Commercial Code No. 6102, Competition Law No. 4054, and applicable sector-specific legislation may also affect the legal analysis.
This guide examines the rights and obligations of foreign investors and Turkish sellers when a company acquisition cannot be completed because regulatory approval is delayed, refused, or made subject to unacceptable conditions.
Not every acquisition of a Turkish company requires advance governmental approval.
However, certain transactions are subject to mandatory regulatory review because of their economic significance, the nature of the target company’s business, or restrictions applicable to particular regulated activities.
For example, an acquisition may require competition clearance if it constitutes a notifiable concentration under the applicable merger control rules.
Transactions involving banks, insurance companies, payment institutions, energy businesses, broadcasting operations, or other regulated activities may also require sector-specific approval or notification.
Some transactions may involve additional requirements relating to ownership structures, licensing, national security, or other regulated matters.
The parties must identify the applicable requirements before signing or closing.
The existence of a regulatory approval requirement does not necessarily prohibit the parties from signing an acquisition agreement. However, completing a transaction before obtaining mandatory clearance may create serious legal consequences.
The consequences depend on whether approval was a legal requirement, a contractual condition, or both.
Where the acquisition agreement makes regulatory approval a condition precedent to closing, the parties generally must examine whether that condition has been satisfied, waived where legally permissible, or has become incapable of satisfaction.
If mandatory approval is refused, the transaction may be unable to close in its proposed form.
The agreement may allow termination after a specified date or upon a final regulatory refusal.
However, termination does not necessarily resolve every financial issue.
The parties may still dispute deposits, break fees, professional expenses, financing costs, confidentiality obligations, and liability for conduct that contributed to the failure.
There is no universal rule placing every regulatory failure loss on either the buyer or the seller.
The acquisition agreement is usually the starting point.
A well-drafted share purchase agreement may expressly allocate responsibility for obtaining approvals, paying filing fees, cooperating with regulators, accepting remedies, and bearing transaction expenses.
If neither party breached its obligations and a properly drafted condition precedent fails, each party may be required to bear its own expenses, subject to the agreement.
If the buyer failed to submit an application despite a binding obligation to do so, the seller may have grounds for a contractual claim.
If the seller concealed a licensing problem that caused approval to be refused, the buyer may have grounds for compensation or other relief.
The outcome therefore requires an examination of both the contractual allocation of risk and the actual cause of the regulatory failure.
A condition precedent is a contractual requirement that must be satisfied before a specified obligation, commonly the obligation to complete the acquisition, becomes due.
In Turkish mergers and acquisitions, regulatory conditions precedent may include competition clearance, sectoral authorization, or approval of a change in control.
The agreement should identify the relevant authority, the required approval, the responsible party, and the deadline for satisfaction.
It should also address whether conditional approval is sufficient and whether either party must accept regulatory remedies.
A condition precedent does not necessarily mean that no binding contractual obligations exist before closing.
The parties may remain bound by confidentiality, cooperation, exclusivity, notification, and other interim obligations.
Where mandatory approval is legally required before closing, the buyer generally should not proceed in violation of that requirement.
If the agreement makes approval a condition precedent, the buyer may also be contractually entitled not to complete the transaction while the condition remains unsatisfied.
However, the buyer must examine whether it has complied with its own obligations to pursue approval.
A buyer who deliberately prevents satisfaction of a condition may face a different legal position from a buyer who diligently pursues clearance but receives a refusal.
Turkish Code of Obligations Article 175 may be relevant where a party acts contrary to good faith in preventing or bringing about the satisfaction of a condition.
The application of that provision requires careful analysis of the facts and the agreement.
A seller cannot rely on a private agreement to override mandatory regulatory requirements.
If the transaction legally requires prior approval, the parties must comply with the applicable legislation.
However, where the dispute concerns a contractual approval condition rather than an absolute legal prohibition, the contractual language may be decisive.
The seller may argue that the buyer waived a condition or failed to fulfill its approval obligations.
Any waiver must be legally permissible and consistent with the agreement.
Mandatory regulatory clearance cannot simply be replaced by the parties’ private consent.
Potentially.
The legal treatment of a deposit depends on the agreement and the nature of the payment.
An advance payment toward the purchase price may be refundable if the transaction fails under circumstances specified in the agreement.
A payment intended as contractual security or a withdrawal payment may have different consequences.
Turkish Code of Obligations Articles 177 and 178 address certain payments made upon conclusion of a contract, but the classification of a particular acquisition deposit depends on its actual legal character and contractual wording.
The buyer should examine whether the agreement expressly states when the deposit must be returned, retained, or applied toward damages.
The failure of regulatory approval does not automatically establish that the seller may keep the entire deposit.
The buyer should first identify the contractual basis for repayment.
Relevant provisions may include the conditions precedent, termination clause, deposit arrangement, escrow agreement, and dispute resolution clause.
If the seller retains funds without a valid legal basis, the buyer may consider contractual repayment or other applicable claims.
Turkish Code of Obligations provisions concerning unjust enrichment may also become relevant in appropriate circumstances.
However, the buyer must distinguish a refundable advance from an enforceable contractual payment allocated to a particular termination event.
A formal demand should be prepared with attention to the agreement’s notice requirements.
Possibly, where the contract validly allocates that risk to the buyer and the relevant conditions are satisfied.
For example, the agreement may provide that the buyer bears specified consequences if it fails to make required filings or breaches its obligation to pursue clearance.
However, a seller cannot automatically retain a deposit merely because the acquisition did not close.
The buyer’s actual obligations, the cause of failure, and the nature of the payment must be examined.
Contractual penalties and other agreed financial consequences may also be subject to applicable mandatory rules.
This situation can create substantial legal risk.
If mandatory approval was required before completion, payment of the purchase price does not necessarily establish that the transaction could lawfully close.
The buyer should examine whether the payment was held in escrow, transferred directly to the seller, or made under another contractual arrangement.
If the acquisition cannot proceed, the parties may need to address repayment and restitution.
The buyer may also need to consider whether premature implementation created regulatory exposure.
The correct remedy depends on the transaction structure and applicable law.
A long-stop date is the contractual deadline by which specified closing conditions must generally be satisfied.
If regulatory approval has not been obtained by that date, the agreement may permit one or both parties to terminate.
However, the termination right may be restricted where the party seeking termination caused the failure through its own breach.
Some agreements allow automatic extensions where regulatory review is continuing.
Others require written agreement to extend the deadline.
The buyer should review the long-stop date before signing and monitor it throughout the approval process.
Potentially, if the agreement provides that right and the relevant conditions are satisfied.
The buyer should examine whether the long-stop date has passed, whether any automatic extension applies, and whether the buyer has complied with its regulatory obligations.
Termination may require formal written notice.
The buyer should also consider which provisions survive termination, including confidentiality, costs, dispute resolution, and accrued claims.
A contractual termination right should be exercised in accordance with the agreement.
The seller’s right to terminate depends on the agreement and any applicable legal grounds.
A seller may not necessarily terminate merely because regulatory review is taking longer than expected.
If the buyer is complying with its obligations and the deadline has not expired, premature termination may itself create contractual liability.
Conversely, a material breach of the buyer’s filing or cooperation obligations may trigger specific remedies.
The parties should distinguish delay by the authority from delay caused by a contracting party.
Regulatory delay does not necessarily mean that approval has been refused.
The legal effect depends on the applicable regulatory procedure and the acquisition agreement.
Some regulatory regimes contain statutory review periods, extensions, or rules concerning the consequences of administrative silence.
The parties should not assume that silence constitutes approval unless the applicable legislation expressly supports that conclusion.
The agreement may permit extensions where review is ongoing.
The parties should document their communications with the authority and assess whether additional information is required.
A buyer may face liability if it breaches a contractual obligation to pursue approval diligently.
Relevant conduct may include failing to submit required documents, withholding necessary information, or intentionally delaying filings.
The seller may argue that the buyer prevented satisfaction of the condition precedent.
Turkish Code of Obligations Article 175 and contractual cooperation provisions may be relevant, depending on the circumstances.
The seller must establish the applicable legal requirements and any recoverable loss.
The seller may be required to provide corporate documents, financial information, ownership records, and other materials necessary for regulatory review.
If the agreement imposes a cooperation obligation, unjustified refusal may constitute a breach.
The buyer should preserve requests for information and the seller’s responses.
The legal consequences depend on whether the missing cooperation caused delay or refusal and what remedies the agreement provides.
Concealed licensing problems may create a separate legal claim.
For example, the seller may represent that the target company holds all necessary operating licenses when a material license has already been suspended or is subject to cancellation proceedings.
If the undisclosed issue prevents approval of the acquisition, the buyer may investigate a warranty breach or fraudulent concealment.
The buyer should examine the seller’s knowledge, the disclosure schedules, and the relevant regulatory correspondence.
The existence of a licensing problem does not automatically prove intentional deception.
Potentially.
Turkish Code of Obligations Article 36 addresses fraudulent deception affecting contractual consent.
If the seller knowingly provides false information about the target company’s regulatory status and that deception induces the buyer to enter into the agreement, remedies may be available.
The buyer must establish the relevant legal elements.
Article 39 establishes an important one-year period for the relevant declaration following discovery of the deception.
The buyer should distinguish a contractual warranty breach from intentional deception, as the claims have different requirements.
Possibly, but not automatically.
Foreign investors frequently incur substantial costs for financial due diligence, legal reviews, tax investigations, environmental assessments, and regulatory advice.
The agreement may state that each party bears its own transaction costs regardless of whether closing occurs.
Alternatively, the buyer may have a damages claim where the seller’s actionable breach caused recoverable expenses.
The buyer must establish the applicable legal basis, causation, and amount.
Expenses that would have been incurred even without the breach require careful treatment.
The answer depends on the agreement and applicable law.
The parties may expressly allocate responsibility for filing fees and professional expenses.
Where no special arrangement exists, the buyer should examine whether a breach of contract provides a basis for recovering particular costs.
The buyer should preserve invoices, engagement letters, payment records, and evidence of the expenses incurred.
Not every professional fee is automatically recoverable from the other party.
Potentially, where the applicable legal requirements are satisfied.
A foreign buyer may incur financing arrangement fees, commitment fees, interest, and hedging costs in preparation for closing.
If the transaction fails because of an actionable breach by the seller, the buyer may seek recovery of qualifying financial losses.
However, the buyer must establish causation and any applicable contractual limitations.
The buyer should also examine whether financing arrangements were conditional on regulatory approval.
Yes, where the buyer breached an enforceable obligation and the seller establishes a recoverable loss.
For example, the seller may allege that the buyer failed to make a mandatory filing despite a contractual commitment.
The seller may also claim that the buyer deliberately prevented regulatory approval.
However, the mere failure of a condition precedent does not automatically establish buyer liability.
The seller must identify the relevant breach and prove the applicable requirements for damages.
Not automatically.
The fact that an acquisition fails does not necessarily entitle the seller to recover the full purchase price while retaining ownership of the company.
Any damages claim must reflect the applicable legal basis, contractual provisions, and actual recoverable loss.
The seller may seek compensation for certain losses caused by a breach, but the calculation must avoid double recovery.
A claim for lost transaction value requires careful legal and financial analysis.
Potentially, depending on the contractual and statutory basis of the claim.
The seller may argue that the buyer’s breach caused it to lose a valuable transaction or alternative sale opportunity.
However, speculative expectations are not sufficient by themselves.
The seller must establish causation, recoverability, and the amount of loss.
The applicable agreement may also exclude or limit certain categories of damages.
A reverse break fee is a contractual payment that the buyer may be required to make if the acquisition fails under specified circumstances.
It is often used to allocate particular closing risks, including financing or regulatory risks.
For example, the agreement may require the buyer to pay a specified amount if competition clearance is not obtained by the long-stop date.
The clause must be examined carefully to determine its legal character and enforceability.
A reverse break fee is not automatically payable whenever an acquisition fails.
Their enforceability depends on the contractual structure, governing law, and applicable mandatory provisions.
A payment described as a reverse break fee may function as an agreed termination payment, a contractual penalty, or another form of risk allocation.
Turkish Code of Obligations Articles 179–182 regulate contractual penalties.
Article 182 provides for judicial reduction of excessive penalties in circumstances governed by that provision.
However, Turkish Commercial Code Article 22 restricts certain requests by merchants for reduction of contractual penalties, subject to the applicable legal framework and mandatory-law considerations.
The precise characterization of the payment is therefore important.
Potentially, if the contractual conditions for payment have not been satisfied or another valid defense applies.
The buyer should examine whether the fee is triggered by any regulatory refusal or only by failure attributable to the buyer.
The agreement may contain exceptions for seller breaches, inaccurate warranties, or specified regulatory events.
The buyer should also consider whether mandatory legal rules affect the provision.
Unilateral refusal without a valid basis may create additional contractual exposure.
Conditional approval may create a dispute about whether the condition precedent has been satisfied.
The authority may require divestments, behavioral commitments, governance restrictions, or other remedies within its legal powers.
The buyer may argue that the conditions fundamentally change the commercial value of the acquisition.
The seller may argue that the buyer is required to accept reasonable conditions.
The outcome depends on the regulatory decision and the acquisition agreement’s allocation of remedy obligations.
Not necessarily.
The agreement may require the buyer to use reasonable efforts, best efforts, or another specified standard to obtain approval.
Some agreements contain a so-called hell-or-high-water obligation requiring the buyer to accept extensive regulatory remedies, subject to the clause’s wording and applicable law.
Other agreements expressly exclude obligations to divest material assets or accept burdensome restrictions.
The buyer should examine the precise scope of its commitments.
General cooperation language does not automatically require acceptance of every regulatory condition.
A hell-or-high-water clause is a contractual mechanism allocating substantial regulatory approval risk to the buyer.
Depending on its wording, the buyer may be required to take extensive measures to secure clearance.
These measures may include proposing remedies, restructuring operations, or disposing of specified assets.
However, the clause’s scope must be determined through contractual interpretation.
It does not authorize conduct contrary to mandatory law.
Foreign investors should assess the potential financial consequences before accepting such a provision.
The buyer should determine whether the acquisition agreement requires acceptance of divestment obligations.
A divestment may reduce the expected commercial benefits of the transaction.
The agreement may contain a materiality threshold or expressly exclude certain assets from required remedies.
If the buyer is not contractually required to accept the divestment, refusal may be permissible.
If the buyer accepted a broader regulatory efforts obligation, the analysis may be different.
Commercial unattractiveness does not automatically create a right to terminate.
The buyer must identify a contractual or statutory basis for refusing to close.
A material adverse change clause, regulatory condition, or specific remedy limitation may be relevant.
The buyer should not assume that a decline in expected profitability automatically releases it from contractual obligations.
The exact agreement and regulatory decision must be reviewed.
Yes, if the seller agrees.
The parties may renegotiate the price where regulatory conditions materially affect the target company’s value.
However, the buyer does not automatically acquire a unilateral right to reduce the purchase price.
The agreement may contain a specific adjustment mechanism or termination right.
Any amendment should comply with applicable contractual formalities and regulatory requirements.
A refusal of competition clearance may prevent the transaction from proceeding in its proposed form.
The parties should examine the authority’s decision, the applicable legal remedies, and the acquisition agreement.
Potential responses may include challenging the decision through available procedures, restructuring the transaction, proposing lawful remedies, or terminating under the contract.
The parties must consider the relevant deadlines and whether an alternative structure would itself require notification.
A competition refusal does not automatically establish wrongdoing by either contracting party.
Competition Law No. 4054 and the applicable merger control regulations govern notifiable concentrations.
Communiqué No. 2010/4 and its amendments establish important rules concerning mergers and acquisitions requiring authorization.
The applicability of notification requirements depends on the transaction structure, the acquisition of control, the relevant turnover thresholds, and other regulatory criteria.
Those thresholds and criteria may change through amendments.
Foreign investors should verify the rules in force at the relevant filing date rather than relying on historical thresholds.
A transaction involving a foreign buyer may still require Turkish competition clearance where the applicable jurisdictional requirements are satisfied.
Where a transaction requires prior competition authorization, implementing it before obtaining clearance may violate the applicable merger control rules.
The parties should distinguish signing the agreement from completing or implementing the transaction.
Premature transfer of control or other conduct amounting to implementation may create regulatory exposure.
The parties should also assess whether interim governance arrangements or information-sharing practices raise separate competition concerns.
A private contractual agreement does not eliminate mandatory merger control requirements.
Gun-jumping generally refers to premature implementation of a transaction that requires prior competition clearance.
It may involve transferring control or taking other steps that amount to implementing the concentration before authorization.
The legal analysis depends on the actual conduct and applicable merger control rules.
The parties should avoid assuming that all pre-closing cooperation is prohibited or that every operational arrangement is permissible.
Regulatory counsel should assess interim covenants and implementation plans before closing.
Liability for regulatory fines depends on the applicable legislation and the conduct involved.
The acquisition agreement may allocate the economic burden of specified fines between buyer and seller.
However, private contractual allocation does not necessarily change which person or undertaking is legally liable to the regulator.
The parties should distinguish regulatory liability from contractual indemnification rights.
Yes.
Transactions involving banks may be subject to sector-specific approval requirements under the applicable banking legislation.
Ownership changes and transfers of qualifying shareholdings may trigger regulatory review.
The buyer should examine the relevant authorization requirements, the target’s regulatory status, and the acquisition agreement.
A refusal may prevent completion and create disputes concerning deposits, costs, and contractual obligations.
Acquisitions involving regulated insurance businesses may require sector-specific review under the applicable insurance legislation.
The approval process may consider ownership, financial capacity, governance, and other regulatory requirements.
The parties should identify the exact authorization needed and the consequences of refusal.
The financial allocation of a failed transaction depends on the agreement and any actionable breach.
Yes.
Certain acquisitions involving licensed energy businesses may require approval or compliance with change-of-control rules under the relevant energy legislation.
The requirements depend on the type of license, transaction structure, and applicable regulatory provisions.
A foreign investor should examine these requirements before signing.
The seller’s representations concerning licenses and regulatory compliance may be particularly important.
Acquisitions involving payment institutions or electronic money institutions may be subject to specific regulatory requirements.
The buyer should assess ownership approvals, licensing conditions, and any restrictions on changes in control.
A failure to obtain approval may prevent closing or require restructuring.
The contractual allocation of regulatory risk determines many of the financial consequences.
Potentially.
Certain regulated sectors may impose ownership restrictions, eligibility requirements, or special approval procedures.
The buyer should identify whether the proposed ownership structure is legally permissible.
If the seller represented that no ownership restriction applied, an inaccurate representation may create contractual issues.
If the buyer was responsible for assessing its own eligibility, the agreement may allocate that risk differently.
The buyer should determine whether the approval refusal resulted from its corporate structure, beneficial ownership, financial qualifications, or another regulatory issue.
The acquisition agreement may allocate responsibility for buyer-specific regulatory eligibility.
A seller may argue that the buyer assumed the risk of obtaining approval for its own ownership structure.
However, liability depends on the agreement and the parties’ conduct.
This may support a claim against the seller.
For example, undisclosed licensing violations, regulatory investigations, or compliance failures may prevent approval.
The buyer should determine whether the seller warranted regulatory compliance or disclosed all material investigations.
If those representations were inaccurate, contractual remedies may be available.
The buyer must establish the breach and recoverable loss.
An expired or invalid license may affect the company’s ability to operate and the feasibility of the acquisition.
The buyer should investigate whether the seller disclosed the licensing status.
The share purchase agreement may contain representations that all material permits are valid and in force.
If those representations were inaccurate, the buyer may consider a warranty claim.
The availability of regulatory approval and the financial consequences must be assessed separately.
The relevant authority may consider the buyer’s financial qualifications under applicable sector-specific rules.
If approval is refused because the buyer does not satisfy a known regulatory requirement, the agreement may allocate that risk to the buyer.
However, the buyer’s contractual liability is not automatic.
The relevant representations, approval obligations, and termination provisions must be examined.
Incomplete or inaccurate information may delay or jeopardize the approval process.
The buyer should determine whether it breached a contractual filing or cooperation obligation.
The seller may seek remedies if the breach caused a recoverable loss.
However, not every request for additional information establishes contractual wrongdoing.
Regulatory procedures frequently involve supplemental submissions.
False regulatory submissions may create serious legal and contractual consequences.
The buyer should determine who prepared the information, who authorized its submission, and whether the inaccuracies affected the authority’s decision.
If the seller breached contractual representations or cooperation obligations, the buyer may have remedies.
Potential regulatory or criminal consequences require separate analysis under the applicable legislation.
Turkish law recognizes the principle of good faith, including under Article 2 of the Turkish Civil Code.
Good faith may be relevant to the interpretation and performance of contractual obligations.
A party that deliberately obstructs the approval process may face legal consequences.
However, the buyer should identify specific contractual duties and statutory grounds rather than relying solely on a general allegation of unfairness.
Not automatically.
The refusal of regulatory approval does not necessarily constitute force majeure.
The parties should examine the agreement’s definition of force majeure and the applicable legal requirements.
A regulatory refusal may instead be addressed through a specific condition precedent or termination clause.
The buyer should avoid treating all governmental decisions as legally equivalent to force majeure events.
Potentially, depending on the nature of the regulatory refusal and the applicable law.
Turkish Code of Obligations Article 136 addresses certain situations involving impossibility of performance for which the debtor is not responsible.
However, the application of impossibility rules depends on the relevant obligation, the legal circumstances, and the contractual allocation of risk.
A temporary delay or conditional approval is not necessarily equivalent to definitive impossibility.
The parties should examine whether the agreement already provides a specific mechanism for regulatory failure.
The parties should determine whether the change was caused by new legislation, a regulatory decision, or another event.
The agreement may allocate the risk of changes in law or regulatory policy.
If the condition precedent can no longer be satisfied, termination or other contractual consequences may follow.
Whether damages are payable depends on the applicable legal and contractual framework.
Turkish Code of Obligations Article 138 regulates hardship under specified conditions.
However, hardship does not automatically entitle a party to terminate or rewrite an acquisition agreement because regulatory approval becomes more expensive or commercially unattractive.
The statutory requirements are demanding and must be assessed alongside the contract’s risk allocation.
A specific regulatory condition or termination provision may be more directly relevant.
A change in regulatory policy may affect the feasibility or cost of obtaining approval.
The parties should determine whether the change was foreseeable, whether the agreement allocates regulatory change risk, and whether alternative compliance measures are available.
Neither party is automatically responsible for every external regulatory development.
The legal consequences depend on the agreement and applicable law.
Potentially, depending on the authority, decision, and applicable procedural framework.
Certain administrative decisions may be subject to judicial review.
The competent court, filing deadline, and available remedies depend on the relevant legislation.
The buyer should also consider whether challenging the decision extends the acquisition agreement’s long-stop date.
A regulatory challenge does not automatically suspend contractual deadlines.
Only where the agreement or another applicable legal obligation provides a sufficient basis.
The parties may agree that the buyer must pursue available administrative or judicial remedies within defined limits.
However, a general obligation to cooperate does not necessarily require unlimited litigation against a regulator.
The scope of the buyer’s efforts obligation must be examined.
The seller may argue that the buyer failed to use the required efforts to obtain approval.
The buyer may respond that an appeal was not contractually required, was legally unavailable, or fell outside the agreed obligation.
The outcome depends on the agreement and circumstances.
The seller must establish any alleged breach and resulting loss.
Potentially.
The parties may consider modifying the transaction structure, reducing the acquired shareholding, excluding certain assets, or proposing lawful regulatory remedies.
However, restructuring must comply with applicable legislation.
A revised transaction may require a new notification or additional regulatory review.
The parties should also examine whether the agreement requires cooperation in pursuing alternatives.
Possibly, but a minority acquisition is not automatically exempt from regulatory requirements.
The relevant analysis may depend on control rights, voting arrangements, governance provisions, and sector-specific ownership thresholds.
A minority investment that confers control may still be relevant under merger control rules.
The buyer should obtain transaction-specific regulatory advice before adopting an alternative structure.
The seller’s obligation depends on the acquisition agreement.
A seller may not be required to accept a materially different transaction unless it agreed to do so.
The buyer should determine whether the contract contains a cooperation or restructuring obligation.
A proposed alternative may require amendments to the purchase price, governance arrangements, or closing conditions.
Potentially, if the agreement provides for a seller-paid break fee and the relevant conditions are satisfied.
The buyer should examine the trigger events, exclusions, and payment procedure.
The legal characterization and enforceability of the fee depend on the governing law and contractual terms.
A break fee is not automatically payable merely because approval was refused.
The buyer should review exclusivity, non-solicitation, and interim covenant provisions.
If the seller accepted a competing offer in breach of an enforceable obligation, the buyer may have contractual remedies.
The failure of regulatory approval does not necessarily excuse an earlier breach of exclusivity.
The buyer must establish the relevant breach and recoverable loss.
Potentially, but the claim must satisfy the applicable legal requirements.
The buyer may argue that it declined alternative acquisitions while pursuing the Turkish transaction.
However, lost opportunities can be difficult to establish and quantify.
The buyer should provide reliable evidence of the alternative opportunity, the causal connection, and the recoverable financial consequences.
Speculative expectations are insufficient by themselves.
The seller may rely on a clause allocating regulatory approval risk to the buyer.
The buyer should examine whether the clause covers all regulatory events or only specified risks.
A broad allocation provision must be interpreted alongside the seller’s warranties and cooperation obligations.
The buyer’s assumption of regulatory risk does not necessarily eliminate liability for separate actionable seller misconduct.
Such a provision may significantly affect recovery of transaction expenses.
However, the buyer should determine whether the clause applies to ordinary termination expenses, breach-related damages, or both.
The agreement may contain separate indemnification or fraud provisions.
The entire contractual framework must be considered.
Potentially, depending on the clause’s wording and applicable law.
Some agreements provide that neither party is liable when an approval condition fails without breach.
Others preserve liability for pre-termination breaches, intentional misconduct, or fraud.
Turkish Code of Obligations Article 115 restricts advance exclusions of liability for intentional wrongdoing and gross negligence.
The buyer should distinguish a legitimate allocation of regulatory risk from an attempted exclusion of liability for actionable misconduct.
An undisclosed investigation may affect the likelihood of approval.
The buyer should examine whether the seller warranted that no material regulatory proceedings were pending.
If the investigation was known before signing but concealed, the buyer may have a contractual claim.
Where the facts support intentional deception, statutory remedies may also be relevant.
The buyer must establish the connection between the undisclosed investigation and the claimed loss.
The agreement may restrict material operational changes between signing and closing.
If the seller changes the target company’s activities in breach of an interim covenant and the change causes regulatory refusal, the buyer may investigate a contractual claim.
The buyer should examine the ordinary-course covenant, approval requirements, and evidence of causation.
Not every business change automatically creates liability.
Pre-closing asset transfers may affect the target company’s value or regulatory status.
The buyer should determine whether the transfers were permitted by the agreement.
The seller may have breached interim covenants, asset preservation obligations, or financial representations.
The legal consequences depend on the transaction documents and applicable law.
Potentially.
Turkish Civil Procedure Code Articles 389 and following regulate interim injunctions.
An injunction may be available where the statutory requirements are satisfied and the requested measure protects an appropriate underlying right.
However, the buyer must identify the specific legal interest requiring protection.
An injunction is not automatically available merely because a transaction has failed.
Precautionary attachment may be available for qualifying monetary claims under Articles 257 and following of Enforcement and Bankruptcy Law No. 2004.
The buyer must satisfy the statutory requirements.
The court may require security.
A disputed deposit refund or damages claim does not automatically justify attachment.
The buyer should assess the evidence and applicable procedural conditions.
The buyer should examine where the funds were transferred and whether the seller has assets available for enforcement.
A transfer abroad does not automatically establish wrongdoing.
However, the buyer may need to consider cross-border enforcement and asset protection strategies.
The governing agreement and relevant jurisdictions will affect the available options.
Potentially.
The competent forum depends on the acquisition agreement, the parties, and the applicable jurisdiction rules.
A Turkish commercial court may have jurisdiction in certain disputes.
However, an arbitration clause or valid jurisdiction agreement may require a different forum.
The buyer should identify the appropriate procedure before filing.
Turkish Commercial Code Article 5/A establishes mandatory mediation for certain commercial monetary lawsuits within its statutory scope.
Whether mediation is required depends on the nature of the claim and the applicable procedural framework.
The parties should not assume that every failed acquisition dispute is subject to the same requirement.
The effect of an arbitration clause must also be examined.
A valid arbitration clause may require the parties to resolve their contractual dispute through arbitration.
The agreement may specify the seat, institution, language, and applicable procedural rules.
Claims concerning deposits, break fees, regulatory cooperation, and damages may fall within the clause’s scope.
The parties should also examine whether urgent interim measures are available.
Potentially.
The New York Convention and applicable Turkish legislation may provide a framework for recognizing and enforcing qualifying foreign arbitral awards.
The creditor must satisfy the relevant enforcement requirements.
Obtaining an award does not automatically guarantee collection.
The availability of assets and possible enforcement objections should be assessed.
Foreign judgments may be recognized or enforced in Turkey under the applicable provisions of International Private and Procedural Law No. 5718.
The buyer should examine the statutory requirements and potential refusal grounds.
A foreign judgment does not automatically authorize execution against Turkish assets without the required legal process.
The share purchase agreement may designate foreign substantive law.
The effectiveness and scope of the choice-of-law provision require examination under applicable private international law rules.
Mandatory Turkish regulatory requirements may still apply to a transaction involving a Turkish business.
The buyer should distinguish contractual governing law from regulatory compliance and jurisdiction.
The legal consequences depend on the agreement and applicable regulatory framework.
A foreign individual may be subject to particular eligibility or ownership requirements in regulated sectors.
The buyer should determine whether approval was refused because of personal qualifications or another issue.
The contractual allocation of that risk remains important.
In many circumstances, foreign investors may appoint authorized legal counsel to manage the dispute.
A power of attorney may be required.
Authentication, translation, and procedural requirements depend on the circumstances.
Personal attendance may still be necessary for certain proceedings.
The relevant deadlines depend on the legal basis and the acquisition agreement.
Contractual notice provisions, deposit repayment deadlines, and limitation periods may apply.
Turkish Code of Obligations Article 146 establishes a general ten-year limitation period for certain claims where no special period applies.
Different periods may govern other claims.
Article 39 is particularly relevant to rights arising from fraudulent deception.
The buyer should obtain a transaction-specific limitation analysis promptly.
Important evidence may include the share purchase agreement, regulatory condition provisions, filing records, authority correspondence, deposit payment documents, escrow arrangements, due diligence reports, and communications between the parties.
The buyer should also preserve evidence showing which party was responsible for particular filings and whether the parties complied with cooperation obligations.
A detailed chronology should identify the signing date, filing date, regulatory requests, responses, refusal or conditional approval, and long-stop date.
The buyer should document the financial losses claimed and their connection to the alleged breach.
Potentially.
Turkish Civil Procedure Code Articles 400–405 regulate evidence preservation.
This may be relevant where important documents or electronic records risk becoming unavailable.
The buyer must satisfy the applicable procedural requirements.
Evidence preservation does not automatically establish liability but may assist in securing relevant material.
The notice should identify the regulatory failure, relevant contractual provisions, and the remedy sought.
If the buyer demands repayment of a deposit, the notice should explain the contractual basis and amount.
If the buyer alleges breach, the notice should identify the relevant conduct and supporting evidence.
The buyer should comply with contractual notification procedures and deadlines.
Unsupported allegations should be avoided.
Yes.
A negotiated settlement may resolve disputes concerning deposits, break fees, expenses, and outstanding obligations.
The parties may agree on repayment arrangements, partial compensation, or a revised transaction structure where legally permissible.
Settlement terms should address payment security, confidentiality, releases, and the consequences of nonperformance.
A settlement should not assume that regulatory requirements can be waived by private agreement.
Failed acquisitions involving regulatory approval may engage several areas of Turkish law.
Turkish Code of Obligations No. 6098 provides rules concerning contractual obligations, conditional transactions, damages, fraudulent deception, impossibility, hardship, and contractual penalties.
Article 112 may be relevant to liability for breach of contractual obligations.
Article 175 addresses certain consequences of conduct contrary to good faith affecting contractual conditions.
Articles 136 and 138 may become relevant to impossibility and hardship where their statutory requirements are satisfied.
Articles 177–178 address particular payments made upon conclusion of a contract, while Articles 179–182 regulate contractual penalties.
Articles 36 and 39 may be relevant where a party alleges fraudulent deception.
Turkish Commercial Code No. 6102 governs important corporate and commercial matters, including aspects of commercial disputes and mandatory mediation under Article 5/A.
Competition Law No. 4054 and the applicable merger control regulations govern qualifying concentrations requiring competition clearance.
Sector-specific legislation may impose additional approval requirements for regulated businesses.
Turkish Civil Procedure Code No. 6100 governs evidence, interim injunctions, and other procedural measures.
Enforcement and Bankruptcy Law No. 2004 may become relevant where a party seeks precautionary attachment or enforcement.
International Private and Procedural Law No. 5718 may govern questions involving foreign elements, applicable law, jurisdiction, and enforcement of foreign judgments.
The relevant regulatory framework must be identified for each transaction, and any approval thresholds or sector-specific rules should be verified as of the applicable date.
A strong legal case begins with identifying the exact approval requirement.
The buyer should determine which authority was responsible, whether approval was legally mandatory, and whether the relevant application was submitted correctly.
The next issue is contractual risk allocation.
The buyer should examine the conditions precedent, cooperation obligations, efforts standards, long-stop date, termination provisions, deposits, and break fees.
The buyer must then establish why approval was not obtained.
A refusal caused by an external regulatory decision may create a different legal position from a refusal caused by inaccurate seller information or the buyer’s failure to cooperate.
The financial analysis should distinguish ordinary transaction expenses from losses caused by an actionable breach.
Finally, the buyer should assess contractual notice requirements, limitation periods, dispute resolution provisions, and enforcement risks.
The objective is to identify a specific legal obligation, establish how it was breached, and demonstrate the remedy available under the agreement and applicable law.
Regulatory approval disputes cannot be resolved solely by asking which party wanted the acquisition to proceed.
The parties may have allocated regulatory risk in different ways.
A buyer may accept responsibility for obtaining competition clearance while the seller remains responsible for maintaining the target company’s licenses and providing accurate regulatory information.
A condition precedent may excuse the parties from closing if approval is refused, while separate obligations concerning cooperation, deposits, and confidentiality continue to apply.
The financial consequences also require careful analysis.
The buyer’s due diligence expenses, financing costs, deposit, and lost opportunities may involve different legal bases.
Similarly, the seller’s claims for a break fee or damages depend on the agreement and the circumstances of failure.
A comprehensive legal strategy must therefore integrate regulatory compliance, contractual interpretation, factual evidence, financial analysis, and enforcement planning.
1. Who pays the losses if regulatory approval for a Turkish company acquisition is refused?
The answer depends on the acquisition agreement, the applicable regulatory framework, and whether either party breached an enforceable obligation. There is no automatic rule placing all losses on one party.
2. Can a foreign buyer recover its deposit if approval is not obtained?
Potentially. The buyer must examine the deposit provisions, termination conditions, and the legal character of the payment.
3. Can the Turkish seller keep the deposit after regulatory refusal?
Only where a valid contractual or legal basis supports retention. Regulatory refusal alone does not automatically entitle the seller to keep every deposit.
4. Can the buyer terminate the acquisition after the long-stop date?
Potentially, where the agreement permits termination and the relevant conditions are satisfied.
5. What if the seller concealed a regulatory licensing problem?
The buyer may have contractual or other legal remedies if the seller breached a warranty, disclosure obligation, or engaged in actionable deception.
6. Must the buyer accept regulatory conditions that make the acquisition less profitable?
Not necessarily. The answer depends on the agreement’s regulatory efforts obligations and any limitations on required remedies.
7. Can the seller demand a reverse break fee?
Potentially, if the agreement contains an enforceable provision and its payment conditions have been satisfied.
8. Can a foreign buyer sue in Turkey after a failed acquisition?
Potentially. Jurisdiction depends on the agreement, the parties, and applicable procedural rules. Arbitration may be required if the parties agreed to it.
9. Can the buyer recover due diligence and financing expenses?
Possibly, where the agreement or another applicable legal basis permits recovery and the buyer establishes the relevant loss.
10. What should a foreign investor do immediately after regulatory approval is refused?
The investor should preserve the regulatory decision and related correspondence, review termination and notice deadlines, assess the deposit and break fee provisions, and obtain legal advice before taking further contractual action.
The failure to obtain regulatory approval for a Turkish company acquisition can result in significant financial losses, disputed deposits, financing expenses, contractual penalties, and complex disagreements between foreign buyers and Turkish sellers.
These disputes frequently involve share purchase agreements, competition clearance, sector-specific licensing requirements, conditions precedent, regulatory cooperation obligations, and termination rights.
Fırat Fesih Kaya Law Office provides legal assistance to foreign investors and international companies involved in Turkish mergers and acquisitions, cross-border commercial disputes, contractual indemnification claims, and post-closing litigation.
Lawyer Fırat Fesih Kaya assists clients with reviewing acquisition agreements, evaluating regulatory conditions, assessing responsibility for failed transactions, preparing deposit recovery and compensation claims, and examining litigation, arbitration, and enforcement options under Turkish law.
Foreign investors facing a failed acquisition because regulatory approval was not obtained should seek legal advice promptly to protect their contractual rights, preserve evidence, and avoid missing applicable deadlines.
Call Now: +90 312 434 22 22
WhatsApp: +90 532 769 22 22
Email: info@firatfesihkaya.av.tr
Website: https://www.firatfesihkaya.av.tr
Disclaimer: This article is intended for general informational purposes only. To avoid any loss of legal rights, we recommend consulting your lawyer regarding the specific circumstances of your case.